$INO SEC Filings

Filed On	Filing
06 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year This Amendment (the “Amendment”) to the Amended and Restated Bylaws (the “Bylaws”) of Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Corporation”), is made effective as of the date first above written in accordance with Artic...
12 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition
07 Aug 2026	SCHEDULE 13G
06 Aug 2026	SCHEDULE 13G/A
31 Jul 2026	SCHEDULE 13G
31 Jul 2026	8-K: Entry into a Material Definitive Agreement; Other Events
30 Jul 2026	424B5
29 Jul 2026	424B5
29 Jul 2026	8-K: Results of Operations and Financial Condition
10 Jul 2026	EFFECT
02 Jul 2026	S-3
26 May 2026	S-8
21 May 2026	Form 4: Yarno Wendy L, Director Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit
21 May 2026	Form 4: Shepard Jay, Director Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit
21 May 2026	Form 4: Miller Ann Calby, Director Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit
21 May 2026	Form 4: Weiner David B., Director Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit
21 May 2026	Form 4: Zoth Lota S., Director Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit
21 May 2026	Form 4: Dansey Roger D, Director Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit

Comments